Ekso Bionics Holdings Inc (EKSO)
0.89
+0.02
(+2.18%)
USD |
NASDAQ |
Nov 05, 16:00
0.89
0.00 (0.00%)
After-Hours: 16:26
Ekso Bionics Holdings Gross Profit Margin (Quarterly): 53.50% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 53.50% |
| June 30, 2024 | 53.27% |
| March 31, 2024 | 51.94% |
| December 31, 2023 | 48.88% |
| September 30, 2023 | 53.31% |
| June 30, 2023 | 47.93% |
| March 31, 2023 | 48.52% |
| December 31, 2022 | 47.25% |
| September 30, 2022 | 50.65% |
| June 30, 2022 | 47.36% |
| March 31, 2022 | 47.10% |
| December 31, 2021 | 59.25% |
| September 30, 2021 | 59.27% |
| June 30, 2021 | 58.44% |
| March 31, 2021 | 64.66% |
| December 31, 2020 | 60.38% |
| September 30, 2020 | 62.58% |
| June 30, 2020 | 55.61% |
| March 31, 2020 | 43.39% |
| December 31, 2019 | 49.87% |
| September 30, 2019 | 52.73% |
| June 30, 2019 | 47.82% |
| Date | Value |
|---|---|
| March 31, 2019 | 44.22% |
| December 31, 2018 | 45.21% |
| September 30, 2018 | 42.47% |
| June 30, 2018 | 32.59% |
| March 31, 2018 | 30.46% |
| December 31, 2017 | 31.68% |
| September 30, 2017 | 34.06% |
| June 30, 2017 | 21.21% |
| March 31, 2017 | 24.51% |
| December 31, 2016 | 32.59% |
| September 30, 2016 | 25.25% |
| June 30, 2016 | 13.08% |
| March 31, 2016 | 17.65% |
| December 31, 2015 | -9.98% |
| September 30, 2015 | 16.05% |
| June 30, 2015 | 23.75% |
| March 31, 2015 | 23.86% |
| December 31, 2014 | 37.44% |
| September 30, 2014 | 30.21% |
| June 30, 2014 | 3.81% |
| March 31, 2014 | 45.16% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
43.39%
Minimum
Mar 2020
64.66%
Maximum
Mar 2021
53.16%
Average
52.61%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | -6.96% |
| InfuSystems Holdings Inc | 49.46% |
| Xtant Medical Holdings Inc | 62.06% |
| Catheter Precision Inc | 82.80% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -80.84% |
| Return on Assets | -38.32% |
| Return on Invested Capital | -56.77% |
| Profit Margin (Quarterly) | -50.18% |
| Operating Margin (Quarterly) | -63.91% |
| Return on Net Operating Assets | -40.23% |